ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Get a quick snapshot of today’s dividend ETF expense ratios and what they mean for your potential returns, with tips for comparing funds.
18,562 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
July markets showed a cautious tone as Ondas revealed a fresh $70 million order backlog. The stock jumped, while majo...
Tech leadership returns as Nvidia and Meta strengthen AI bets. This rally lifted major indexes and helped smaller gro...
Talkspace stock surged today as investors responded to stronger-than-expected results and improving unit economics. T...
NEAR token surged recently, signaling renewed market interest. This guide unpacks the drivers behind the near protoco...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
Oil shocks aren’t just headlines. This guide breaks down five real ways a $100 oil price affects your wallet and your...
A single AI stock could outperform the rest on Nasdaq by the end of 2026. This article breaks down why that might hap...
The EUAD ETF has rebounded, prompting investors to focus on three defense stocks to watch as European budgets firm up...
Chip stocks rise on liquidity-driven rotations, but Morgan Stanley’s CIO cautions this may be near peak rather than a...
A new CLO-focused bond fund is drawing cash away from traditional cash substitutes by offering roughly 7% yields, but...
A major fund trims a big stake in a tech name, sparking questions about risk, sector exposure, and portfolio resilien...